Publications by authors named "Stacey Rudd"

Claim this Profile
L
Looking backward to move forward: a chemist's perspective on the future of radiopharmaceuticals.
Stacey E Rudd

J Biol Inorg Chem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential theranostics of breast cancer with copper-64/67 sarcophagine-trastuzumab.
Stacey E Rudd, Jessica Van Zuylekom, Carleen Cullinane, Benjamin J Blyth, Paul S Donnelly

Chem Sci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Positron Emission Tomography Imaging with Zirconium-89 Desferrioxamine B Squaramide: From Bench to Bedside.
Stacey E Rudd, Asif Noor, Katherine A Morgan, Paul S Donnelly

Acc Chem Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copper(II) Complexes of 2,2'-dipyrrins: Synthesis, Characterization, Cell Uptake, and Radiolabeling with Copper-64.
Jacob A Rowan, Stacey E Rudd, Katherine Ganio, Christopher A McDevitt, Jonathan M White

Inorg Chem· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 Positron Emission Tomography Imaging in Patients With Non-Small Cell Lung Cancer: Preliminary Results of the ImmunoPET Phase 0 Study.
Fiona Hegi-Johnson, Stacey E Rudd, Christian W Wichmann, Tim Akhurst, Peter Roselt

Int J Radiat Oncol Biol Phys· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Theranostic Nuclear Medicine with Gallium-68, Lutetium-177, Copper-64/67, Actinium-225, and Lead-212/203 Radionuclides.
Katherine A Morgan, Stacey E Rudd, Asif Noor, Paul S Donnelly

Chem Rev· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated radiosynthesis of [Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo.
Christian W Wichmann, Stan Poniger, Nancy Guo, Peter Roselt, Stacey E Rudd

Nucl Med Biol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocol.
Fiona Hegi-Johnson, Stacey E Rudd, Christian Wichmann, Tim Akhurst, Peter Roselt

BMJ Open· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging immunity in patients with cancer using positron emission tomography.
Fiona Hegi-Johnson, Stacey Rudd, Rodney J Hicks, Dirk De Ruysscher, Joseph A Trapani

NPJ Precis Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models.
Vasilios Liapis, William Tieu, Nicole L Wittwer, Tessa Gargett, Andreas Evdokiou, Stacey E Rudd

Mol Imaging Biol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models.
Vasilios Liapis, William Tieu, Nicole L Wittwer, Tessa Gargett, Andreas Evdokiou, Stacey E Rudd

Mol Imaging Biol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging Somatostatin Positive Tumors with Tyr-Octreotate/Octreotide Conjugated to Desferrioxamine B Squaramide Radiolabeled with either Zirconium-89 or Gallium-68.
Asif Noor, Jessica K Van Zuylekom, Stacey E Rudd, Peter D Roselt, Mohammad B Haskali

Bioconjug Chem· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzyme mediated incorporation of zirconium-89 or copper-64 into a fragment antibody for same day imaging of epidermal growth factor receptor.
Stacey E Rudd, Jessica K Van Zuylekom, Anna Raicevic, Lesley A Pearce, Carleen Cullinane

Chem Sci· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved non-invasive positron emission tomographic imaging of chemotherapy-induced tumor cell death using Zirconium-89-labeled APOMAB®.
Vasilios Liapis, William Tieu, Stacey E Rudd, Paul S Donnelly, Nicole L Wittwer

EJNMMI Radiopharm Chem· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bivalent Inhibitors of Prostate-Specific Membrane Antigen Conjugated to Desferrioxamine B Squaramide Labeled with Zirconium-89 or Gallium-68 for Diagnostic Imaging of Prostate Cancer.
Asif Noor, Jessica K Van Zuylekom, Stacey E Rudd, Kelly Waldeck, Peter D Roselt

J Med Chem· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
and Evaluation of Zr-DS-8273a as a Theranostic for Anti-Death Receptor 5 Therapy.
Ingrid J G Burvenich, Fook-Thean Lee, Nancy Guo, Hui K Gan, Angela Rigopoulos, Stacey E Rudd

Theranostics· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodies.
Stacey E Rudd, Peter Roselt, Carleen Cullinane, Rodney J Hicks, Paul S Donnelly

Chem Commun (Camb)· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodies.
Stacey E Rudd, Peter Roselt, Carleen Cullinane, Rodney J Hicks, Paul S Donnelly

Chem Commun (Camb)· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A versatile approach for the site-specific modification of recombinant antibodies using a combination of enzyme-mediated bioconjugation and click chemistry.
Karen Alt, Brett M Paterson, Erik Westein, Stacey E Rudd, Stan S Poniger

Angew Chem Int Ed Engl· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis